MINNEAPOLIS, Jan. 20, 2011 /PRNewswire/ -- Uroplasty, Inc.
(Nasdaq: UPI) announced today that it will release financial
results for the third quarter ended December
31, 2010, at the market close on Thursday, January 27, 2011. The Company
will host a conference call to discuss these results on
Thursday, January 27, 2011 at
4:30 p.m. Eastern Time (3:30 p.m. Central Time). David Kaysen, President and Chief Executive
Officer, and Medi Jiwani, Vice
President, Chief Financial Officer and Treasurer, will host the
call. Individuals wishing to participate in the conference
call should dial 877-941-8609. An audio replay will be available
for 30 days following the call at 800-406-7325 (domestic) and
303-590-3030 (international), with the passcode 4402505#.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned
subsidiaries in The Netherlands
and the United Kingdom, is a
medical device company that develops, manufactures and markets
innovative proprietary products for the treatment of voiding
dysfunctions. Our focus is the continued commercialization of our
Urgent PC system, which we believe is the only FDA-approved
minimally invasive nerve stimulation device designed for
office-based treatment of urinary urgency, urinary frequency and
urge incontinence – symptoms often associated with overactive
bladder.
We also offer Macroplastique Implants, an injectable urethral
bulking agent for the treatment of adult female stress urinary
incontinence primarily due to intrinsic sphincter deficiency. For
more information on the company and its products, please visit
Uroplasty, Inc. at www.uroplasty.com.
For Further
Information:
Uroplasty, Inc.
David Kaysen, President and CEO,
or
Medi Jiwani, Vice President,
CFO, Treasurer
952.426.6140
|
EVC Group
Doug Sherk (Investors),
415.896.6820
Jenifer Kirtland (Investors),
415.896.2005
Chris Gale (Media),
646.201.5431
|
|
|
|
SOURCE Uroplasty, Inc.